PharmaNews

Oncology Research and Treatment · Published 2025-07-23 · DOI 10.1159/000547597

Authors being retrieved — see the publisher record. https://doi.org/10.1159/000547597

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Society Bulletins · Oncology Research and Treatment · 2025 · Same journal
• Society Bulletins · Oncology Research and Treatment · 2026 · Same journal
• Safety and Preliminary Activity of Neoadjuvant Trastuzumab Deruxtecan plus 5-Fluorouracil and Folinic Acid for HER2-Positive, Resectable Esophagogastric Adenocarcinoma: Results from the Safety Run-In Cohort of the Phase Ib/II UCCL-AIO-STO0124-IKF072 NeoART Trial · Oncology Research and Treatment · 2026 · Same journal
• Multiples Myelom – Therapie mit Melflufen · Oncology Research and Treatment · 2026 · Same journal
• Vulnerability to Infections and Secondary Immunodeficiencies in Patients with Non-Hodgkin’s Lymphomas Starting Anti-CD20 Antibody-Containing Therapies · Oncology Research and Treatment · 2026 · Same journal
• Management of Metastatic Prostate Cancer · Oncology Research and Treatment · 2025 · Same journal
• Society Bulletins · Oncology Research and Treatment · 2025 · Same journal
• PharmaNews · Oncology Research and Treatment · 2025 · Same journal
• PharmaNews · Oncology Research and Treatment · 2025 · Same journal
• Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie 24. bis 27. Oktober 2025, Köln: Abstracts · Oncology Research and Treatment · 2025 · Same journal